Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

85.64 +1.38 (+1.63%)
Streaming Delayed Price Updated: 1:08 PM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
21 22 Next >
News headline image
Looking Into Edwards Lifesciences's Recent Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint ↗
Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent actions aim to ensure fair competition, affordability, as Meril alleges... 
Via Benzinga
Topics Intellectual Property
News headline image
Is It Time To Get Defensive With Healthcare Stocks? ↗
Based in Irvine, California, Edwards Lifesciences is a prominent American medical technology firm. 
Via Talk Markets
News headline image
Assessing Edwards Lifesciences: Insights From 11 Financial Analysts ↗
 
Via Benzinga
News headline image
Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy' ↗
Cramer likes Delta Air Lines, United Airlines Holdings. "Now, remember, they're very inexpensive stocks, but they trade wildly. But I do like Delta," he added. 
Via Benzinga
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today ↗
 
Via Benzinga
News headline image
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture? ↗
 
Via Benzinga
News headline image
Behind the Scenes of Edwards Lifesciences's Latest Options Trends ↗
 
Via Benzinga
News headline image
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review ↗
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. 
Via Investor's Business Daily
News headline image
EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024 ↗
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff ↗
The company also raised its outlook for the year and now expects 8% to 10% sales growth. 
Via Investor's Business Daily
News headline image
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Edwards Lifesciences? ↗
 
Via Benzinga
News headline image
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The 5 Stocks Most Sold By Insiders This Year
Insiders are selling these 5 stocks increased as their markets advanced, and gains may be capped. Long-term outlooks are positive for growth and share prices. 
Via MarketBeat
News headline image
What Analysts Are Saying About Edwards Lifesciences Stock ↗
 
Via Benzinga
News headline image
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings For Edwards Lifesciences ↗
 
Via Benzinga
News headline image
What 9 Analyst Ratings Have To Say About Edwards Lifesciences ↗
 
Via Benzinga
News headline image
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark ↗
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81. 
Via Investor's Business Daily
News headline image
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Looking Into Edwards Lifesciences's Recent Short Interest ↗
 
Via Benzinga
News headline image
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom ↗
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.